RPRX insider trading
Open-market stock trades by Royalty Pharma (RPRX) executives and directors: who bought or sold, how many shares, at what price and when.
RPRX insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 4,126 | $57.10 | $235.59K |
| Sep 28, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 4,126 | $57.88 | $238.81K |
| Sep 22, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 96,073 | $58.51 | $5.62M |
| Sep 22, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 3,927 | $58.93 | $231.40K |
| Aug 18, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 100,000 | $59.97 | $6.00M |
| Aug 13, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 9,230 | $58.59 | $540.75K |
| Aug 13, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,772 | $59.14 | $104.80K |
| Jul 1, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 9,099 | $55.88 | $508.45K |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 97,446 | $56.50 | $5.51M |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 2,554 | $57.10 | $145.84K |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 29,400 | $56.44 | $1.66M |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 600 | $57.09 | $34.25K |
| Jun 24, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 9,098 | $55.18 | $502.07K |
| Jun 23, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 32,408 | $54.11 | $1.75M |
| Jun 23, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell | 117,592 | $54.47 | $6.41M |
| May 26, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 64,399 | $53.98 | $3.48M |
| May 20, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 13,684 | $52.75 | $721.84K |
| May 14, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 13,684 | $53.06 | $726.14K |
| May 14, 2026 | Norden Gregory | director | Sell | 3,045 | $53.00 | $161.38K |
| Apr 28, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,875 | $49.78 | $93.33K |
| Apr 28, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 32,916 | $49.78 | $1.64M |
| Apr 1, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,875 | $48.33 | $90.62K |
| Apr 1, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 32,916 | $48.33 | $1.59M |
| Mar 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 32,916 | $45.53 | $1.50M |
| Mar 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,875 | $45.53 | $85.37K |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 22,487 | $46.67 | $1.05M |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 10,429 | $47.01 | $490.31K |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,292 | $46.67 | $60.30K |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 583 | $47.01 | $27.41K |
| Feb 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 32,916 | $45.32 | $1.49M |
| Feb 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,875 | $45.32 | $84.97K |
| Feb 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 102,581 | $42.08 | $4.32M |
| Feb 3, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 108,759 | $42.84 | $4.66M |
| Feb 4, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 19,076 | $43.29 | $825.85K |
| Feb 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 5,843 | $42.08 | $245.90K |
| Feb 3, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 6,195 | $42.84 | $265.41K |
| Feb 4, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 1,087 | $43.29 | $47.06K |
| Jan 30, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 20,000 | $41.09 | $821.81K |
| Jan 23, 2026 | Urist Marshall | EVP, Research & Investments | Sell | 20,000 | $40.26 | $805.11K |
| Jan 20, 2026 | Coyne Terrance P. | EVP & CFO | Sell | 65,832 | $39.35 | $2.59M |
- RPRX insiders bought $0.00 and sold $57.35M in open-market trades over their last 40 filings.
Updated 2026-11-03 00:02 UTC